FDA Inspection 1062455 — American Red Cross Biomedical Services
The FDA completed an inspection of American Red Cross Biomedical Services on July 18, 2018 in Mountain Home, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 18, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mountain Home, AR (United States)